S. Lee

发表

S. Woo, M. Schubert, S. Lee, 1997, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

M. Aljurf, J. Szer, J. Wingard, 2012, Bone Marrow Transplantation.

Th1 and Th2 mediate acute graft-versus-host disease, each with distinct end-organ targets.

R. Bronson, M. Sykes, M. Grusby, 2000, The Journal of clinical investigation.

Oral chronic GVHD outcomes and resource utilization: a subanalysis from the chronic GVHD consortium.

J. Pidala, M. Arora, N. Treister, 2016, Oral diseases.

disease: a multicenter study Performance of a new clinical grading system for chronic graft-versus-host

J. Lynch, M. Horowitz, Stephanie J. Lee, 2013 .

Quality of life associated with acute and chronic graft-versus-host disease

R. Soiffer, C. Cutler, Haesook T. Kim, 2006, Bone Marrow Transplantation.

M. Weinstein, K. Kuntz, Shaun Parsons, 1997, Annals of Internal Medicine.

Factors associated with post-traumatic stress symptoms experienced in the acute phase following haemopoietic stem cell transplant

B. Pillay, S. Burney, L. Katona, 2016, Bone Marrow Transplantation.

The effect of pretransplant interferon therapy on the outcome of unrelated donor hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia in first chronic phase.

J. Klein, M. Horowitz, C. Anasetti, 2001, Blood.

CLONAL HEMATOPOIESIS IN RELATED ALLOGENEIC TRANSPLANT DONORS: IMPLICATIONS FOR SCREENING AND MANAGEMENT.

B. Shaw, G. Switzer, B. Logan, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Seven Years of Experiences of Preclinical Experiments of Xeno-Heart Transplantation of Pig to Non-Human Primate (Cynomolgus Monkey).

K. Park, S. Lee, I. Yun, 2018, Transplantation proceedings.

Proteomic Characterization Reveals That MMP‐3 Correlates With Bronchiolitis Obliterans Syndrome Following Allogeneic Hematopoietic Cell and Lung Transplantation

Philip R. Gafken, Y. Ogata, P. Gafken, 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Initial therapy for chronic myelogenous leukemia: playing the odds.

M. Horowitz, C. Anasetti, J. Antin, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Biomarkers in chronic graft-versus-host disease: quo vadis?

E. Weissinger, E. Holler, J. Hansen, 2018, Bone Marrow Transplantation.

Adoptive immunotherapy with donor mononuclear cell infusions to treat relapse of acute leukemia or myelodysplasia after allogeneic bone marrow transplantation.

D. Porter, J. Ferrara, J. Antin, 1996, Bone marrow transplantation.

Development, preliminary usability and accuracy testing of the EBMT ‘eGVHD App’ to support GvHD assessment according to NIH criteria—a proof of concept

F. Dobbels, S. Geest, H. Greinix, 2016, Bone Marrow Transplantation.

Efficacy and costs of granulocyte colony-stimulating factor in allogeneic T-cell depleted bone marrow transplantation.

J. Ritz, R. Soiffer, E. Weller, 1998, Blood.

Evaluation of EPI-X4 as a urinary peptide biomarker for diagnosis and prognosis of late acute GvHD

O. Zirafi, N. Roan, S. Lee, 2016, Bone Marrow Transplantation.

Polymorphism in the Interleukin‐7 Receptor‐alpha and Outcome after Allogeneic Hematopoietic Cell Transplantation with Matched Unrelated Donor

S. Spellman, L. Ryder, M. Haagenson, 2013, Scandinavian journal of immunology.

Treatment of chronic graft-versus-host disease with clofazimine.

B. Bierer, J. Antin, S. Lee, 1997, Blood.

Comparative outcomes of T-cell-depleted and non-T-cell-depleted allogeneic bone marrow transplantation for chronic myelogenous leukemia: impact of donor lymphocyte infusion.

J. Ritz, R. Soiffer, E. Weller, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Recovery after stem-cell transplantation for hematologic diseases.

D. Fairclough, Shaun Parsons, J. Weeks, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Donor safety: the role of the WMDA in ensuring the safety of volunteer unrelated donors: clinical and ethical considerations

H. Greinix, B. Shaw, M. Pulsipher, 2010, Bone Marrow Transplantation.

Comorbidity burden in patients with chronic GVHD

W. Wood, B. Storer, J. Pidala, 2013, Bone Marrow Transplantation.

Prognostic factors for early severe pulmonary complications after hematopoietic stem cell transplantation.

R. Soiffer, E. Weller, J. Antin, 2001, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Routine screening for psychosocial distress following hematopoietic stem cell transplantation

P. Richardson, D. Fisher, R. Soiffer, 2005, Bone Marrow Transplantation.

M. Aljurf, J. Szer, J. Wingard, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Donor whole blood DNA methylation is not a strong predictor of acute graft versus host disease in unrelated donor allogeneic haematopoietic cell transplantation

P. Dhami, V. Rakyan, A. Feber, 2022, medRxiv.

Family donor care management: principles and recommendations

B. Shaw, M. Pulsipher, K. Douglas, 2010, Bone Marrow Transplantation.

The psychosocial impact of haematopoietic SCT on sibling donors

B. Pillay, S. Burney, L. Katona, 2012, Bone Marrow Transplantation.

Lower costs associated with hematopoietic cell transplantation using reduced intensity vs high-dose regimens for hematological malignancy

D. Zahrieh, R. Soiffer, A. Saito, 2007, Bone Marrow Transplantation.

Direct-to-consumer advertising in oncology: A content analysis of print media.

G. Abel, J. Weeks, S. Lee, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Partial CD8+ T-cell depletion of allogeneic peripheral blood stem cell transplantation is insufficient to prevent graft-versus-host disease

D. Fisher, R. Soiffer, E. Milford, 2004, Bone Marrow Transplantation.

Discrepancies between patient and physician estimates for the success of stem cell transplantation.

D. Fairclough, J. Weeks, D. Fairclough, 2001, JAMA.

Novel HLA-DP region susceptibility loci associated with severe acute GvHD

R. Ferrell, S. Spellman, M. Trucco, 2017, Bone Marrow Transplantation.

Outcomes research in oncology: history, conceptual framework, and trends in the literature.

C. Earle, J. Weeks, S. Lee, 2000, Journal of the National Cancer Institute.

CD6+ donor marrow T-cell depletion as the sole form of graft-versus-host disease prophylaxis in patients undergoing allogeneic bone marrow transplant from unrelated donors.

J. Ritz, A. Freedman, P. Mauch, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Measurement of oral chronic GVHD: results from the Chronic GVHD Consortium

B. Kurland, J. Pidala, M. Flowers, 2013, Bone Marrow Transplantation.

HLA-C mismatch is associated with inferior survival after unrelated donor non-myeloablative hematopoietic stem cell transplantation

R. Soiffer, E. Milford, C. Cutler, 2006, Bone Marrow Transplantation.

J. Wingard, A. Tichelli, S. Davies, 2006, Bone Marrow Transplantation.

Biologic markers of chronic GVHD

S. Roedder, M. Sarwal, J. Pidala, 2014, Bone Marrow Transplantation.

Predicting costs of stem-cell transplantation.

J. Weeks, N. Klar, J. Antin, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

YKL-40 in allogeneic hematopoietic cell transplantation after AML and myelodysplastic syndrome

S. Spellman, C. Müller, M. Verneris, 2016, Bone Marrow Transplantation.

Impact of prior acute GVHD on chronic GVHD outcomes: a chronic graft versus host disease consortium study

B. Kurland, J. Pidala, M. Arora, 2013, Leukemia.

Practice variation in physician referral for allogeneic hematopoietic cell transplantation

J. Pidala, G. Quinn, C. Anasetti, 2012, Bone Marrow Transplantation.

The costs and cost-effectiveness of unrelated donor bone marrow transplantation for chronic phase chronic myelogenous leukemia.

K. Kuntz, J. Weeks, C. Anasetti, 1998, Blood.

Chronic graft-versus-host disease: implications of the National Institutes of Health consensus development project on criteria for clinical trials

G. Socié, G. Vogelsang, S. Lee, 2006, Bone Marrow Transplantation.

Directionality of non-permissive HLA-DPB1 T-cell epitope group mismatches does not improve clinical risk stratification in 8/8 matched unrelated donor hematopoietic cell transplantation

J. Pidala, B. Shaw, S. Spellman, 2017, Bone Marrow Transplantation.

High prevalence of metabolic syndrome after allogeneic hematopoietic cell transplantation

K. Ness, M. Flowers, M. Arora, 2009, Bone Marrow Transplantation.

Race/ethnicity affects the probability of finding an HLA-A, -B, -C and -DRB1 allele-matched unrelated donor and likelihood of subsequent transplant utilization

M. Schell, J. Perkins, J. Pidala, 2013, Bone Marrow Transplantation.

Pre-transplantation physical and mental functioning is strongly associated with self-reported recovery from stem cell transplantation

F. Loberiza, S. Lee, Sj Lee, 2006, Bone Marrow Transplantation.

Safety and efficacy of a quinolone-based regimen for treatment of tuberculosis in renal transplant recipients.

C. Park, Y. S. Kim, H. Yoon, 2012, Transplantation proceedings.

Identification of high-risk amino-acid substitutions in hematopoietic cell transplantation: a challenging task

T. A. Binkowski, T. Karrison, M. Maiers, 2016, Bone Marrow Transplantation.

Efficacy of leflunomide in combination with current immunosuppressive agents in rat cardiac allotransplantation.

D. Candinas, J. Buckels, P. Mcmaster, 1994, Transplantation Proceedings.

Measurement of Oral Chronic Graft-Versus-Host Disease

B. Kurland, J. Pidala, M. Flowers, 2012 .

B. Kurland, M. Flowers, M. Arora, 2012 .

434 Association of skin response in erythema and sclerosis with survival in chronic graft-versus-host disease

Heidi Chen, E. Tkaczyk, M. Jagasia, 2020 .

Can we agree on patient-reported outcome measures for assessing hematopoietic cell transplantation patients? A study from the CIBMTR and BMT CTN

W. Wood, M. Horowitz, B. Shaw, 2016, Bone Marrow Transplantation.

Personality influences quality-of-life assessments in adult patients after allogeneic hematopoietic SCT: results from a joint evaluation of the prospective German Multicenter Validation Trial and the Fred Hutchinson Cancer Research Center

P. Herzberg, E. Holler, H. Greinix, 2013, Bone Marrow Transplantation.

Clinical utility of late renal allograft biopsies.

H. Kim, S. Lee, W. Cho, 1998, Transplantation proceedings.

Comparative Analysis of the Constitutively Active MPLW515L and JAK2V617F Alleles in a Murine Bone Marrow Transplant Model of Myeloproliferative Disease.

D. Gilliland, Z. Tothova, M. Wadleigh, 2006 .